Aptar Pharma, a global leader in drug delivery systems, services and active material science solutions, announced that the recent approval by the National Medical Products Administration (NMPA) in China of Sinomune Pharmaceutical’s Li Fu metronidazole gel for the treatment of papulopustular rosacea uses Aptar Pharma’s Mezzo+ CS (China Support) Airless dispensing solution for dermal drug delivery.
Encube`s Generic Metronidazole Receives Approval in the U.S.
Kesin Pharma Announces FDA Approval and U.S. Availability of LIKMEZ
Health Canada Issues Recall of Baxter`s Metronidazole Injection, USP: Solution bags may be leaking in affected lots
Sept 25 (Reuters) - The U.S. Food and Drug Administration (FDA) on Monday approved Canadian drugmaker Appili Therapeutics' (APLI.TO) liquid oral form of antibiotic drug metronidazole, offering an alternative to patients who have difficulty taking injections or pills.
Riconpharma' Generic Bismuth Subcitrate Potassium, Metronidazole, Tetracycline Hydrochloride Receives Approval in the U.S.
Encube's Generic Metronidazole Receives Approval in the U.S.
DUBLIN, March 10, 2023 /PRNewswire/ -- Endo International plc (OTC: ENDPQ) announced today that one of its operating companies, Par Pharmaceutical, Inc., has begun shipping the first generic version of Allergan's Pylera® (bismuth subcitrate potassium, metronidazole, tetracycline hydrochloride) 140 mg, 125 mg and 125 mg capsules in the U.S., following final approval from the U.S. Food and Drug Administration of its Abbreviated New Drug Application.
Enforcement Report - Week of February 22, 2023
FDA confirms Paragraph IV Patent Litigation of Metronidazole